National Drive Electric Week – Blink Charging
Aric Ohana, President of Blink Mobility and CEO of Envoy, highlights the groundbreaking initiatives promoting electric car-sharing across the U.S. With Envoy’s presence in 50 cities across 21 states, and the impactful Blue LA program placing 150 EVs in Los Angeles, they’re catalyzing EV adoption at an unprecedented rate. A staggering 85% of their platform’s…
Latest
Blink Charging
National Drive Electric Week – Brendan Jones
Brendan Jones, CEO of Blink Charging, delves into the transformative journey of EV charging both in the U.S. and globally. From the early days of slow L2 charging to the current proliferation of faster L2 and extensive DC fast charging networks, the industry is witnessing monumental milestones. Blink Charging stands committed to fueling this evolution,…
Blink Charging
National Drive Electric Week – Jen Yokely
Jen Yokely, Senior Vice President of Global Marketing at Blink Charging, reflects on the evolution of the EV charging sector. From initially battling range anxiety, the industry is now innovating to bolster driver confidence and cater to their evolving needs, marking a significant shift towards range assurance.
Blink Charging
National Drive Electric Week – Nathalie Young
Nathalie Young, Senior Director of Systems and Technology, expresses enthusiasm about the trajectory of the electric vehicle landscape. Emphasizing the dual advantage of cutting-edge technology and sustainability, she highlights the pivotal role of EVs in diminishing emissions and propelling a greener future.
Blink Charging
National Drive Electric Week – Consuelo Capshaw
Consuelo Capshaw, Territory Sales Manager at Blink Charging, underscores the company’s mission to alleviate range anxiety for EV drivers. By systematically increasing the availability of chargers, Blink Charging is paving the way for more electric vehicles on the road, ensuring a seamless and confident driving experience for all.
Blink Charging
National Drive Electric Week – Siddhartha Kodgi
Siddhartha Kodgi, Vice President of Operations at Blink Charging, emphasizes the company’s readiness to support the increasing adoption of electric vehicles. With an expanded facility in Maryland, Blink is primed to address the surging demand for EV charging. Furthermore, by offering AB charging, Blink ensures compliance with vital biomedical requirements, showcasing versatility and commitment to…
Latest
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…
What’s Next in Preclinical Cancer Immunotherapy Research?
As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
